Atrophic gastritis

Revision as of 13:55, 29 June 2016 by Anthony Gallo (talk | contribs) (Formatting)
Jump to navigation Jump to search

WikiDoc Resources for Atrophic gastritis

Articles

Most recent articles on Atrophic gastritis

Most cited articles on Atrophic gastritis

Review articles on Atrophic gastritis

Articles on Atrophic gastritis in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Atrophic gastritis

Images of Atrophic gastritis

Photos of Atrophic gastritis

Podcasts & MP3s on Atrophic gastritis

Videos on Atrophic gastritis

Evidence Based Medicine

Cochrane Collaboration on Atrophic gastritis

Bandolier on Atrophic gastritis

TRIP on Atrophic gastritis

Clinical Trials

Ongoing Trials on Atrophic gastritis at Clinical Trials.gov

Trial results on Atrophic gastritis

Clinical Trials on Atrophic gastritis at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Atrophic gastritis

NICE Guidance on Atrophic gastritis

NHS PRODIGY Guidance

FDA on Atrophic gastritis

CDC on Atrophic gastritis

Books

Books on Atrophic gastritis

News

Atrophic gastritis in the news

Be alerted to news on Atrophic gastritis

News trends on Atrophic gastritis

Commentary

Blogs on Atrophic gastritis

Definitions

Definitions of Atrophic gastritis

Patient Resources / Community

Patient resources on Atrophic gastritis

Discussion groups on Atrophic gastritis

Patient Handouts on Atrophic gastritis

Directions to Hospitals Treating Atrophic gastritis

Risk calculators and risk factors for Atrophic gastritis

Healthcare Provider Resources

Symptoms of Atrophic gastritis

Causes & Risk Factors for Atrophic gastritis

Diagnostic studies for Atrophic gastritis

Treatment of Atrophic gastritis

Continuing Medical Education (CME)

CME Programs on Atrophic gastritis

International

Atrophic gastritis en Espanol

Atrophic gastritis en Francais

Business

Atrophic gastritis in the Marketplace

Patents on Atrophic gastritis

Experimental / Informatics

List of terms related to Atrophic gastritis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief:

Digestive System

Overview

Atrophic gastritis is a process of chronic inflammation of the stomach mucosa, leading to loss of gastric glandular cells and their eventual replacement by intestinal and fibrous tissues. As a result, the stomach's secretion of essential substances such as hydrochloric acid, pepsin, and intrinsic factor is impaired, leading to digestive problems, vitamin B12 deficiency, and megaloblastic anemia. It can be caused by persistent infection with Helicobacter pylori, or can be autoimmune in origin.

Autoimmune Metaplastic Atrophic Gastritis (AMAG) is an inherited form of atrophic gastritis characterized by an immune response directed toward parietal cells and intrinsic factor. The presence of serum antibodies to parietal cells and to intrinsic factor are characteristic findings. The autoimmune response subsequently leads to the destruction of parietal cell mass which then results in profound hypochlorhydria (and elevated gastrin levels). The inadequate production of intrinsic factor also leads to vitamin B12 malabsorption and pernicious anemia. AMAG is typically confined to the gastric body and fundus

Hypochlorhydria induces G Cell (Gastrin producing) hyperplasia which leads to hypergastrinemia. Gastrin exerts a trophic effect on enterochromaffin-like cells (ECL cells are responsible for histamine secretion) and is hypothesized to be one mechanism to explain the malignant transformation of ECL cells into carcinoid tumors in AMAG.

Patients with AMAG and pernicious anemia are also at increased risk for the development of gastric adenocarcinoma. The optimal endoscopic surveillance strategy is not known but all nodules and polyps should be removed in these patients.

Environmental metaplastic atrophic gastritis (EMAG) is due to environmental factors, such as diet and H. pylori infection. EMAG is typically confined to the body of the stomach. Patients with EMAG are also at increased risk of gastric carcinoma.

Recent research has shown that AMAG is a result of the immune system attacking the parietal cells,the attack is being triggered by H. pylori through a mechanism called molecular mimicry.

Historical Perspective

Classification

Pathophysiology

Causes

Drug Side Effect

Pantoprazole

Differentiating Atrophic gastritis from Other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications, and Prognosis

Natural History

Complications

Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Prevention

References

Template:WS Template:WH